Physician profile
Daniel Niku
NPI 1669859732
$4,229.52
in general payments reported to CMS, 2019-2025
44 companies · $883 in 2025
The $883 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $564 · 2021: $948 · 2022: $641 · 2023: $616 · 2024: $300 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,798.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $783.21 | 2019-2024 | |
| Therapeuticsmd, INC. | $270.39 | 2019-2022 | |
| Sage Therapeutics, LLC | $233.68 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $217.56 | 2019-2022 | |
| Mimedx Group, INC. | $196.69 | 2024-2025 | |
| Pfizer INC. | $184.60 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $172.00 | 2023-2025 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $167.26 | 2021-2025 | |
| Organon LLC | $146.04 | 2021-2025 | Nexplanon |
| Agile Therapeutics, INC. | $129.74 | 2022-2024 | Twirla |
| Exeltis, USA INC. | $127.08 | 2021-2025 | Slynd |
| Evofem Biosciences, INC. | $118.69 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $113.63 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.83 | 2022 | |
| Merck Sharp & Dohme LLC | $93.38 | 2019-2021 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $76.91 | 2019-2021 | |
| Baxter Healthcare | $75.34 | 2022-2023 | Perclot |
| Shield Therapeutics INC | $73.59 | 2023 | Accrufer |
| Scynexis, INC. | $72.99 | 2022 | |
| Medicem INC. | $71.52 | 2021-2023 | |
| Hologic Sales and Service, LLC | $66.82 | 2023-2025 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Intuitive Surgical, INC. | $61.61 | 2023-2025 | Da Vinci Surgical System |
| Lupin INC. | $61.00 | 2019-2020 | |
| Millicent US INC | $45.88 | 2025 | Femlyv, Intrarosa |
| Supernus Pharmaceuticals, INC. | $44.87 | 2025 | Qelbree |
| Glaxosmithkline, LLC. | $44.11 | 2020-2021 | |
| Lilly USA, LLC | $35.82 | 2021 | |
| Aspira Women'S Health INC | $35.70 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.88 | 2019-2020 | |
| Medline Industries LP | $33.33 | 2025 | |
| Ascend Therapeutics US, LLC | $32.44 | 2021-2022 | |
| Vertical Pharmaceuticals, LLC | $30.57 | 2019 | |
| Becton, Dickinson and Company | $28.03 | 2024 | Bd Onclarity |
| Meditrina | $27.97 | 2024 | |
| Exact Sciences Corporation | $27.22 | 2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $25.19 | 2021 | |
| Dermira, INC. | $24.75 | 2020 | |
| Amgen INC. | $24.67 | 2025 | Evenity |
| Amag Pharmaceuticals, INC. | $22.97 | 2019 | |
| Mycovia Pharmaceuticals, INC. | $22.74 | 2023 | Vivjoa |
| Channel Medsystems, INC. | $22.50 | 2022-2023 | |
| Allergan, INC. | $19.52 | 2019 | |
| Coopersurgical, INC. | $19.12 | 2022 | |
| Dysis Medical, INC. | $16.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Niku listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.